Joel D. Pearson

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.

Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.

Journal: Cell reports
Published: November 13, 2025

Molecular basis and therapeutic implications of binary YAPOn/YAPOff cancer classes.

Molecular basis and therapeutic implications of binary YAPOn/YAPOff cancer classes.

Journal: The Biochemical journal
Published: February 14, 2025

Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications.

Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications.

Journal: Cancers
Published: November 15, 2024

Treatment with infliximab and tacrolimus in steroid-refractory pneumonitis secondary to anti-HER2 therapy.

Treatment with infliximab and tacrolimus in steroid-refractory pneumonitis secondary to anti-HER2 therapy.

Journal: ESMO open
Published: September 26, 2024

Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033].

Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033].

Journal: ESMO open
Published: June 13, 2024

Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis.

Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis.

Journal: Cancer research communications
Published: April 04, 2024

Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.

Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.

Journal: Cell reports
Published: January 18, 2024

Cell cycle duration determines oncogenic transformation capacity.

Cell cycle duration determines oncogenic transformation capacity.

Journal: Nature
Published: August 26, 2023

A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone.

A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone.

Journal: ESMO open
Published: June 23, 2023

Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.

Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.

Journal: Cell reports
Published: November 14, 2022

Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application.

Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application.

Journal: PloS one
Published: February 22, 2022

Simplifying cancer: binary pan-cancer superclasses stratified by opposite YAP/TEAD effects.

Simplifying cancer: binary pan-cancer superclasses stratified by opposite YAP/TEAD effects.

Journal: Molecular & cellular oncology
Published: December 03, 2021
Showing 1-12 of 31

Last Updated: 09/26/2026